4//SEC Filing
Hutton Scott 4
Accession 0000905148-25-003930
CIK 0001439725other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:53 PM ET
Size
8.9 KB
Accession
0000905148-25-003930
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Hutton Scott
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Common Stock
2025-11-10+611→ 37,500 total - Sale
Common Stock
2025-11-10$7.62/sh−189$1,440→ 37,311 total - Exercise/Conversion
Restricted Stock Units
2025-11-10−611→ 610 total→ Common Stock (611 underlying)
Footnotes (5)
- [F1]These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025 (the "Reverse Stock Split").
- [F2]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]Includes 448 shares of the Issuer's Common Stock, as adjusted for the Reverse Stock Split, purchased under the Issuer's Employee Stock Purchase Plan on September 2, 2025.
- [F4]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- [F5]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001697361
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:53 PM ET
- Size
- 8.9 KB